AFT Pharmaceuticals P/E 2025

AFT Pharmaceuticals Aktienanalyse

What does AFT Pharmaceuticals do?

AFT Pharmaceuticals Ltd is a New Zealand pharmaceutical company founded in 1997 by Hartley Atkinson. The company is headquartered in Auckland and operates in multiple countries. Business Model: AFT Pharmaceuticals' business model is focused on developing and marketing high-quality products. The company relies on product innovation and regularly introduces new medicines and supplements to the market. The company offers a wide range of products in various therapeutic areas such as pain management, respiratory diseases, gastrointestinal diseases, and skin conditions. AFT Pharmaceuticals has its own research and development facilities where they continuously work on new formulations and prioritize the needs of patients. The company also relies on partnerships to expand its presence globally and distribute its products in new markets. History: AFT Pharmaceuticals was founded in 1997 by Hartley Atkinson, who started by developing painkillers that were more effective and better tolerated than existing products. The company grew rapidly and expanded its offerings to meet additional medical needs. AFT Pharmaceuticals has since become one of the largest pharmaceutical companies in New Zealand and is expanding internationally. Divisions: An important area of AFT Pharmaceuticals is pain management. The company offers painkillers that are effective and safe, available in various forms. The portfolio includes both over-the-counter and prescription medicines that can be used to relieve pain, including migraine products. Another important area is respiratory diseases. AFT Pharmaceuticals manufactures medications that can be used for allergic rhinitis, asthma, and COPD. The medications are available in various forms such as tablets, syrup, inhalers, and nasal sprays. The company also offers products for gastrointestinal diseases that can be used for conditions such as heartburn, nausea, and vomiting. Dermatology is another important area. AFT Pharmaceuticals produces a variety of products that can be used to treat skin conditions such as eczema and psoriasis. Products: One of AFT Pharmaceuticals' most well-known product lines is Maxigesic, a painkiller that contains a combination of paracetamol and ibuprofen. The medication is available in many countries and is prescribed by doctors for a variety of pain types. Another popular product is Flutiform, an inhaler used for asthma and COPD. The inhaler is easy to use and highly effective. AFT Pharmaceuticals also offers a wide range of dietary supplements that contribute to overall health. These include products like Iron-C, a dietary supplement that contains iron and vitamin C to ensure good oxygen supply in the body. Overall, AFT Pharmaceuticals is a successful pharmaceutical company that offers a broad portfolio of medicines and dietary supplements available in many countries. The company relies on innovation and partnerships to expand its global presence. AFT Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering AFT Pharmaceuticals's P/E Ratio

The Price to Earnings (P/E) Ratio of AFT Pharmaceuticals is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing AFT Pharmaceuticals's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of AFT Pharmaceuticals is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in AFT Pharmaceuticals’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about AFT Pharmaceuticals stock

What is the price-to-earnings ratio of AFT Pharmaceuticals?

The price-earnings ratio of AFT Pharmaceuticals is currently 24.02.

How has the price-earnings ratio of AFT Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of AFT Pharmaceuticals has increased by 23.31% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of AFT Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of AFT Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of AFT Pharmaceuticals affect the company?

An increase in the price-earnings ratio of AFT Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of AFT Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of AFT Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of AFT Pharmaceuticals?

Some factors that influence the price-earnings ratio of AFT Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does AFT Pharmaceuticals pay?

Over the past 12 months, AFT Pharmaceuticals paid a dividend of 0.02 NZD . This corresponds to a dividend yield of about 0.66 %. For the coming 12 months, AFT Pharmaceuticals is expected to pay a dividend of 0.02 NZD.

What is the dividend yield of AFT Pharmaceuticals?

The current dividend yield of AFT Pharmaceuticals is 0.66 %.

When does AFT Pharmaceuticals pay dividends?

AFT Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AFT Pharmaceuticals?

AFT Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of AFT Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0.02 NZD are expected. This corresponds to a dividend yield of 0.66 %.

In which sector is AFT Pharmaceuticals located?

AFT Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von AFT Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AFT Pharmaceuticals from 7/4/2025 amounting to 0.018 NZD, you needed to have the stock in your portfolio before the ex-date on 6/18/2025.

When did AFT Pharmaceuticals pay the last dividend?

The last dividend was paid out on 7/4/2025.

What was the dividend of AFT Pharmaceuticals in the year 2024?

In the year 2024, AFT Pharmaceuticals distributed 0.016 NZD as dividends.

In which currency does AFT Pharmaceuticals pay out the dividend?

The dividends of AFT Pharmaceuticals are distributed in NZD.